# Zhejiang Hospital: Not applicable (device, behavioral) study in Coronary Artery Disease (554 participants)

**Score:** 40/100

| Field | Value |
|---|---|
| Sponsor | Zhejiang Hospital |
| Sponsor type | Academic and hospital |
| Study | OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI) |
| NCT ID | NCT07855614 |
| Phase | Not applicable (device, behavioral) |
| Status | not yet recruiting |
| Conditions | Coronary Artery Disease |
| Intervention types | device, procedure |
| Target enrollment | 554 |
| Site countries | China |
| Posted | 2026-10-02 |
| Planned start | 2026-09 |
| Event | Newly registered study |
| Event date | 2026-10-02 |

## Why this score
- 554 participants planned.
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07855614). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.